← Eichor
Study identifier: NCT07062549 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell

Condition: Renal Cell Carcinoma (Kidney Cancer)  ·  Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

PhasePhase 1
Planned participants6
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is being done to determine if the investigational radiotracer called 111In-XYIMSR-01 is helpful in detecting clear cell renal cell carcinoma tissue in your body when used during a SPECT-CT Scan

This description comes directly from the study's public registry record.

Talk to the study team

Yasser Ged, MBBS  ·  410-955-8893  ·  yged1@jhmi.edu

Jasmine Brooks  ·  jbrook54@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07062549